COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 564: Articles 5631-5640  | Next

Modelling the adjustment of COVID-19 response and exit from dynamic zero-COVID in China
Leung, K., Leung, G. M., Wu, J.
10.1101/2022.12.14.22283460 — Posted: 2022-12-14
COVID-19 Vaccination in Pregnancy: The Impact of Multimorbidity and Smoking Status on Vaccine Hesitancy, a Cohort Study of 25,111 Women in Wales, UK
Mhereeg, M., Jones, H., Kennedy, J., Seaborne, M., Parker, M., Kennedy, N., Akbari, A., Zuccolo, L., Azcoaga-Lorenzo, A., Davies, A., Nirantharakumar, K., Brophy, S.
10.1101/2022.12.12.22283200 — Posted: 2022-12-14
Severe Acute Respiratory Syndrome Coronavirus 2 detection in induced sputum of asthmatic patients using saliva sampling device
Moermans, C., Gerday, S., Bricmont, N., Bonhiver, R., Schleich, F., GUIOT, J., Njock, M.-S., Henket, M., Guissard, F., Paulus, V., Di Valentin, E., Minner, F., Gillet, L., Bureau, F., Louis, R.
10.1101/2022.12.12.22283341 — Posted: 2022-12-14
Trivalent SARS-CoV-2 S1 Subunit Protein Vaccination Induces Broad Humoral Responses in BALB/c Mice
Khan, M. S., Kim, E., Huanga, S., Kenniston, T. W., Gambotto, A.
10.1101/2022.12.12.520124 — Posted: 2022-12-14
SARS-CoV-2 vaccine-breakthrough infections (VBIs) by Omicron (B.1.1.529) variant and consequences in structural and functional impact
Abduljaleel, Z., Melebari, S., Dehlawi, S., Kumar S, U., Aziz, S. A., Dannoun, A. I., Malik, S. M., Doss C, G. P.
10.1101/2022.12.12.520021 — Posted: 2022-12-14
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants
Vanhulle, E., Doijen, J., Stroobants, J., Provinciael, B., Noppen, S., Schols, D., Stevaert, A., Vermeire, K.
10.1101/2022.12.13.520307 — Posted: 2022-12-13
Mental Health in Ireland During the Covid Pandemic: Evidence from Two Longitudinal Surveys
Madden, D.
10.1101/2022.12.12.22283343 — Posted: 2022-12-13
Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine, in non-human primates
Prenafeta, A., Bech-Sabat, G., Moros, S., Barreiro, A., Fernandez, A., Canete, M., Roca, M., Gonzalez, L., Garriga, C., Confais, J., Toussenot, M., Contamin, H., Pradenas, E., Marfil, S., Blanco, J., Cebollada Rica, P., Sistere-Oro, M., Meyerhans, A., Pizzorno, A., Rosa-Calatrava, M., Prat Cabanas, T., March, R., Ferrer, L.
10.1101/2022.12.13.520255 — Posted: 2022-12-13
Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Cote dIvoire
Simons, E., Nikolay, B., Ouedraogo, P., Pasquier, E., Tiemeni, C., Adjaho, I., Badjo, C., Chamman, K., Diomande, M., Dosso, M., Doumbia, M., Izia, Y. A., Kakompe, H., Katsomya, A. M., Kij, V., Akissi, V. K., Mambula, C., Mbala-Kingebeni, P., Muzinga, J., Ngoy, B., Penali, L., Pini, A., Porten, K., Salou, H., Sevede, D., Luquero, F., Gignoux, E.
10.1101/2022.12.12.22283387 — Posted: 2022-12-13
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection
Perez-Saez, J., Zaballa, M.-E., Lamour, J., Yerly, S., Dubos, R., Courvoisier, D., Villers, J., Balavoine, J.-F., Pittet, D., Kherad, O., Vuilleumier, N., Kaiser, L., Guessous, I., Stringhini, S., Azman, A. S.
10.1101/2022.12.13.22283400 — Posted: 2022-12-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).